3,4-methylenedioxyamphetamine has been researched along with Chronic Pain in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foglia, MB | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Chronic Pain
| Article | Year |
|---|---|
When People You Love Are The Unintended Consequences Of Opioid Policy.
Topics: Analgesics, Opioid; Chronic Disease; Chronic Pain; Female; Health Policy; Humans; Kidney Failure, Ch | 2019 |